COSM Stock — Cosmos Health Inc.

Cosmos Health Inc. (COSM)

Updated October 16, 2026.

COSM is a Stock. Total return is -97.3% over the past 16.2 years, 917.7 points behind SPY at 820.4%.

Cosmos Health Inc. manufactures and distributes branded pharmaceutical products, medical devices, food supplements, and nutraceuticals across Greece and southeastern Europe under brand names including Sky Premium Life and Mediterranation. The company does not currently distribute to shareholders. Cosmos Health appeals to investors seeking exposure to the regional healthcare and consumer health products sector.

COSM performance versus SPY

Price and return data through 2026-10-16.

Total return is -97.3% over the past 16.2 years, 917.7 points behind SPY at 820.4%. Over the past year its total return — price change plus distributions reinvested — is -69.6%. Its deepest 1-year drawdown was 84.2%.

COSM key facts

Asset type

Stock

Asset class

Equity

Inception date

07/23/2010

Distribution frequency

None

Last close

$0.33 (as of 2026-10-16)

Market cap

$33,339,969

Average volume

1856187.0

Payment date

11/21/2017

Beta

4.213

Payout ratio

0.0%

Forward P/E

5.8445

EPS

$-0.60

How Dividend Vision calculates yield and returns

Distribution rate (the posted rate) uses calculation basis unavailable. Issuer rates can use a different denominator and date, including ex-date NAV. Trailing-12-month yield is the sum of split-adjusted cash distributions with ex-dates in the last 12 months, divided by the published price. It lags a recent raise or cut. Total return uses split-adjusted close with distributions reinvested on the ex-dividend date (a modeling convention, not the cash-settlement date) from the first stored bar on or after inception through the latest bar, compared with the same window on the benchmark. That is the security's total return, not your personal gain/loss.

Yield and safety methodology · Distribution rate methodology · Distribution Safety Score methodology

Sources and review

Primary sources: prices and distributions from Dividend Vision, derived from vendor EOD data.

Reviewed by Bert Sweet, CEO and Co-owner of Dividend Vision. Methodology: Distribution Safety Score.

COSM risks and drawbacks

Total return has trailed SPY over the available window. The deepest 1-year drawdown on record here is 84.2%.

Who may consider COSM — and who may not

It is a weaker fit for investors who need monthly cash flow (COSM does not currently distribute); investors whose main goal is matching SPY total return. This is educational context, not a recommendation to buy or sell.

More on COSM

• All tickers starting with C

Tagged: Healthcare.

Frequently asked questions